磷脂酰肌醇3激酶抑制剂LY294002对缺血缺氧心肌细胞的作用研究

目的:明确P13K/Akt信号通路在缺血缺氧心肌细胞损害中的作用。方法:建立心肌细胞缺血缺氧模型,施加磷脂酰肌醇3激酶抑制剂LY294002干预,观察心肌细胞活力、培养液中乳酸脱氢酶(LDH)含量及碘化丙啶(PI)染色阳性细胞比例的变化。结果:模拟缺血缺氧后细胞活力下降,LDH及PI染色阳性细胞比例显著增加。LY294002干预复合缺血缺氧后,细胞活力急剧下降,LDH含量及PI染色阳性细胞比例进一步显著增加(P<0.01)。结论:应用LY294002加重了缺血缺氧对心肌细胞的损伤效应,提示PI3K/Akt通路参与了缺血缺氧心肌细胞的内源性保护反应,减轻了缺血缺氧损害。     

DCA干预对缺氧复氧肥大心肌细胞能量代谢及细胞凋亡的影响

目的:探讨缺氧复氧损伤诱导体外培养的新生大鼠肥大心肌细胞凋亡及能量代谢途径变化及药物干预的作用.方法:取体外培养的新生大鼠心肌细胞,以血管紧张素Ⅱ诱导其肥大,分4组:一组于3%O2、5%CO2、92%N2三气培养箱中培养12 h,再恢复正常条件培养4h,建立缺氧复氧损伤的肥大心肌细胞模型;另三组加入二氯乙酸盐(DCA)使其终浓度分别为10-3mmol/L、10-4mmol/L和10-5mmol/L,再缺氧复氧相同时间.电镜观察肥大心肌细胞及凋亡细胞的超微结构变化,Hochest33342/PI荧光染色识别凋亡细胞;TUNEL法观察心肌细胞凋亡形态学特征,并记数凋亡心肌细胞数,检测心肌细胞凋亡率;以同位素液闪计数法测定丙酮酸脱氢酶(PDH)内碱脂酰转移酶-1(CPT-1)活性,以及葡萄糖有氧氧化率,葡萄糖酵解率和脂肪酸有氧氧化率.结果:肥大心肌细胞在缺氧12h复氧4h,TUNEL法可检测到阳性的凋亡细胞,凋亡率为(19.99±4.88)%,肥大心肌细胞缺氧培养12h后加入DCA10-3 mmol/L、10-4 mmol/L和10-5 mmol/L再复氧4h检测其凋亡率分别为(16.5±3.24)%、(17.4±3.72)%和(18.4±3.44)%;与正常心肌细胞比较,肥大心肌细胞总的PDH活性没有明显改变.但活化型PDH活性和葡萄糖氧化代谢率(GOR)显著增强,CPT-1活性和脂肪酸有氧氧化代谢率(FOR)显著降低;与对照肥大心肌细胞比较,二氯乙酸(DCA 10-3 mmol/L-DCA 110-3mmol/L)呈剂量依赖性的升高PDH活性和GOR,抑制CPT21活性,FOR和葡萄糖酵解率(glucolysis rate,GLR).结论:DCA对缺氧复氧损伤引起的肥大心肌细胞凋亡有抑制作用.肥大心肌细胞能量代谢向糖代谢转化,DCA可进一步增强糖有氧氧化代谢抑制脂肪酸代谢.     

注射用内给氧对缺血再灌注损伤兔肝脏能量代谢的影响

为了探讨注射用内给氧对肝脏缺血再灌注(I/R)损伤肝脏能量代谢的影响,将48只健康新西兰长耳大白兔随机分为4组:假手术组(A组),缺血再灌注组(B组),缺血再灌注 周围静脉注射用内给氧组(C组),缺血再灌注 肝动脉注射内给氧组(D组),每组12只,采用Pringle氏法建立肝脏I/R模型,比较4组大白兔缺血再灌注后1、2、24h肝组织内三磷酸腺苷(ATP)、二磷酸腺苷(ADP)、一磷酸腺苷(AMP)含量、肝脏的细胞能荷(EC)及肝组织形态学的变化.结果表明,与A组比较,8、C、D三组肝功能损害重,肝组织ATP含量,能荷值(EC)降低(P<0.05);肝组织病理学改变明显(P<0.05),B组以上各项指标差异更为显著,与B组比较,C、D二组肝组织ATP含量,能荷值(EC)高(P<0.05);肝组织病理学改变较轻(P<0.05);C组与D组比较,各参数无显著性差异.以上研究表明.注射用内给氧可通过改善肝细胞的能量代谢而减轻肝缺血再灌注损伤.     

11,12.环氧二十碳三烯酸预处理与后处理对缺血/再灌注大鼠心肌的保护作用

采用Langendorff离体灌流装置,通过停灌40 min/复灌30 min复制大鼠心肌缺血/再灌注(ischemia/reperfusion,IR)损伤模型,观察11,12-环氧二十碳三烯酸(11,12-epoxyeicosatrienoic acid,11,12-EET)预处理和后处理对心肌线粒体功能以及心功能的影响,探讨11,12-EET顸处理和后处理对IR大鼠心肌的作用及其机制.将30只Sprague-Dawley大鼠随机分为对照组、IR组、EET预处理组(Pre-EET)、EET后处理组(Post-EET),每组6只.除对照组外,其它各组全心缺血40 min,再灌注30 min.监测左心室内压差(ALVP)和左心室内压升降的最大变化率(±dp/dtmax)等心功能指标,测定灌流液中乳酸脱氢酶(1actate dehydrogenase,LDH)的活性.灌流结束后,测定心肌线粒体琥珀酸脱氢酶(succinate dehydrogenase,SDH)、Ca"ATPase、Na - K -ATPase活性以及心肌超氧化物歧化酶(superoxide dismutase,SOD)活性、丙二醛(malondialdehyde,MDA)含量.结果显示:(1)与IR组相比,Pre-EET组及Post.EET组Na -K -ATPase和SDH活性均增强,Ca2 -ATPase活性均减弱,有显著性差异(P<0.05);而Pre-EET与Post-EET组间没有显著性差异.(2)与IR组相比,Pre-EET组及Post-EET组心功能明显改善,LDH漏出显著减少,心肌SOD活性明显增强,MDA含量明显降低,有显著性差异(P<0.05);而Pre-EET与Post-EET组间没有显著性差异.结果表明,11,12-EET预处理及后处理均可通过上调心肌线粒体Na -K -ATPase、SDH活性以及下调Ca2 -ATPase活性改善线粒体功能和心肌能量代谢,拮抗心肌IR损伤;11,12-EET预处理及后处理还可通过提高心肌SOD活性、降低MDA含量改善IR心肌的氧化应激.     

阿托伐他汀对自发性高血压大鼠p27蛋白表达及心肌细胞凋亡的影响

目的：观察阿托伐他汀对自发性高血压大鼠（SHR）p27蛋白表达及心肌细胞凋亡的影响。方法：将12只8周龄的雄性SHR随机分为2组（n=6）;蒸馏水饲养组（DW组）与阿托伐他汀治疗组（ATV组）,并以6只同周龄的正常血压大鼠（WKY）作为对照（WKY组）。分别采用RT-PCR与Western blot法检测p27的mRNA及蛋白表达水平;TUNEL法检测心肌细胞的凋亡;同时计算左室重与体重比,检测血脂水平。结果：阿托伐他汀治疗10周后,ATV组与DW组相比较,其①血脂水平及左室重、左室重与体重比均明显降低（P〈0.01）;②p27的mRNA及蛋白表达水平明显上调（P〈0.01）;③心肌细胞的凋亡率显著增高（P〈0.01）。结论：阿托伐他汀能够上调SHR的p27蛋白表达水平、促进其心肌细胞的凋亡,在某种程度上可能与其改善SHR心室肥厚的效应有关。     

Protective effect of exogenous coenzyme Q in rats subjected to partial hepatic ischemia and reperfusion.

In a surgical model of liver ischemia lipid peroxidation occurs, as shown by increase of lipid peroxidation end products, endogenous CoQ9 is oxidized and mitochondrial respiration is lowered; however, pre-treatment of the rats by i.p. injection of CoQ10 for 14 days normalizes the above parameters, presumably by way of the observed high extent of reduction of the incorporated quinone; moreover, liver homogenates of the CoQ10-treated rats are more resistant than those of non-treated rats to oxidative stress induced by an azido free radical initiator. This preliminary study suggests that CoQ10 pre-treatment can be of beneficial effect against oxidative damage during liver surgery transplantation.     

Tolerance of isolated rat hearts to low-flow ischemia and hypoxia of increasing duration: Protective role of down-regulation and ATP during ischemia

We tested the hypothesis that down-regulated hearts, as observed during low-flow ischemia, adapt better to low O₂ supply than non-down-regulated, or hypoxic, hearts. To address the link between down-regulation and endogenous ischemic protection, we compared myocardial tolerance to ischemia and hypoxia of increasing duration. To that end, we exposed buffer-perfused rat hearts to either low-flow ischemia or hypoxia (same O₂ shortage) for 20, 40 or 60 min (n = 8/group), followed by reperfusion or reoxygenation (20 min, full O₂ supply). At the end of the O₂ shortage, the rate·pressure product was less in ischemic than hypoxic hearts (p < 0.0001). The recovery of the rate·pressure product after reperfusion or reoxygenation was not different for t = 20 min, but was better in ischemic than hypoxic hearts for t = 40 and 60 min (p < 0.02 and p < 0.0002, respectively). The end-diastolic pressure remained unchanged during low-flow ischemia (0.024 ± 0.013 mmHg·min^–1), but increased significantly during hypoxia (0.334 ± 0.079 mmHg·min^–1). We conclude that, while the duration of hypoxia progressively impaired the rate·pressure product and the end-diastolic pressure, hearts were insensitive of the duration of low-flow ischemia, thereby providing evidence that myocardial down-regulation protects hearts from injury. Excessive ATP catabolism during ischemia in non-down-regulated hearts impaired myocardial recovery regardless of vascular, blood-related and neuro-hormonal factors. These observations support the view that protection is mediated by the maintenance of the ATP pool.     

丙酮酸钠对失血性休克大鼠缺血/再灌注损伤的保护作用

目的:研究丙酮酸钠对失血性休克后缺血/再灌注损伤的保护作用。方法:制作失血性休克大鼠模型,回输全血,同时分别给予生理盐水、谷胱甘肽和丙酮酸钠适量,于再灌注后3h处死动物。检测血浆乳酸脱氢酶(LDH)和谷草转氨酶(GOT)的活性、组织丙二醛(MDA)的含量和髓过氧化物酶(MPO)的活性,观察心、肝、肺和肾组织的病理变化。结果:丙酮酸钠组与生理盐水组相比,血浆LDH和GOT的活性降低,肝、肺和肾组织MDA的含量下降,心、肺和肾组织MPO活性降低,效果优于谷胱甘肽。心、肝、肺和肾组织形态学观察显示,丙酮酸钠使组织损伤减轻。结论:丙酮酸钠对失血性休克后再灌注损伤具有保护作用。其作用机制可能与清除氧自由基、减少中性粒细胞的浸润、减轻炎性反应有关。     

Protective effects of Glycyrrhizae radix extract and its compounds in a renal hypoxia (ischemia)-reoxygenation (reperfusion) model.

Glycyrrhizae radix water extract (GRWE) and its two major constituents glycyrrhizin and 3-glycyrrhetinic monodesmoside, significantly suppressed LDH leakage and MDA release, whereas glycyrrhetinic acid had no effect. On the other hand, in rats subjected to ischemia-reperfusion, the activities of endogenous antioxidant enzymes including catalase and glutathione peroxidase showed recovery, whereas the levels of urea nitrogen and creatinine in serum were reduced by administration of glycyrrhizin orally for 30 days prior to ischemia-reperfusion. These results indicate that GRWE and its two constituents may be promising for amelioration of hypoxia (ischemia)-reoxygenation (reperfusion) injury and improvement of renal function by acting directly or indirectly as antioxidant and oxygen radical-scavenging agents.     

Myeloperoxidase increased cardiomyocyte protein nitration in mice subjected to nonlethal mechanical trauma

Nonlethal mechanical trauma causes cardiomyocyte apoptosis which contributes to posttraumatic cardiac dysfunction. Apoptosis is positively correlated with protein nitration in the traumatic heart. However, the mechanisms responsible for the cardiomyocyte protein nitration remain unclear. The present study was designed to identify whether myeloperoxidase may contribute to protein nitration in nonlethal mechanical trauma and subsequent cardiomyocyte apoptosis, and, if so, to determine the possible mechanisms responsible. We used Noble-Collip drum to make nonlethal traumatic mice models. Male adult C57B16/J mice were placed in the Noble-Collip drum and subjected to a total of 200 revolutions at a rate of 40 r/min. Then myeloperoxidase activity and release, protein nitration, cardiomyocyte apoptosis, endothelial function and intercellular adhesion molecule-1 expression were determined. Nonlethal mechanical trauma was characterized by the 100% survival rate during the first 24 h after trauma, the lack of circulatory shock and without direct heart injury. However, myeloperoxidase activity significantly increased 6 h after trauma, and reached a maximum level 12 h after trauma. Obviously, protein nitration and cardiomyocyte apoptosis increased 12 h after trauma and could be blocked by administration of R15.7, a monoclonal antibody that blocks polymorphonuclear neutrophils adhesion. Moreover, endothelial dysfunction and intercellular adhesion molecule-1 upregulation were observed in traumatic mice. Our present study demonstrated for the first time that myeloperoxidase caused protein nitration and cardiomyocyte apoptosis in nonlethal traumatic mice. Inhibition of polymorphonuclear neutrophils adhesion and antinitration treatments may be novel measures in reducing posttraumatic cardiomyocyte apoptosis and secondary heart injury.     

Effects of long-term treatment with eicosapentaenoic acid on the heart subjected to ischemia/reperfusion and hypoxia/reoxygenation in rats

The effects of eicosapentaenoic acid (EPA) and long-term treatment with EPA-ethylester (EPA-E) were examined in perfused rat hearts subjected to ischemia/reperfusion and adult rat cardiomyocytes subjected to hypoxia/reoxygenation. EPA (0.1 M) improved postischmic contractile dysfunction of the ischemic/reperfused heart. EPA (10 M) attenuated hypoxia/reoxygenation-induced morphological deterioration of cardiomyocytes. The results suggest the presence of direct cardioprotective effects of EPA. Rats were orally treated for 4 weeks with 1 g/kg/day of EPA-E to elucidate ex vivo effects of EPA, and the fatty acid composition of cardiac phospholipids was determined. The percent ratio of EPA in total fatty acids of cardiac phospholipids increased whereas that of arachidonic acid decreased. The percent ratio of n-3/n-6 fatty acid did not increase. Treatment with EPA-E did not improve the post-ischemic contractile function, but attenuated the ischemia/reperfusion-induced release of prostaglandins during reperfusion. Treatment with EPA-E preserved a better morphological appearance of the cardiomyocytes subjected to hypoxia/reoxygenation. The results suggest that the mechanisms responsible for cytoprotective effects of hypoxic/reoxygeanted cardiomyocytes or inhibition of metabolic alterations of the ischemic/reperfused heart by long-term EPA-E treatment did not contribute substantially to recovery of post-ischemic contractile dysfunction. The direct in vitro effects of EPA may play a role in the protection of the heart from ischemia/reperfusion or hypoxia/reoxygenation injury.     

Diverse effects of L-arginine on cardiac function of rats subjected to myocardial ischemia and reperfusion in vivo

In vivo administration of L-arginine at different time points during the course of myocardialischemia and reperfusion(MI/R)has been shown to differentially regulate postischemic apoptosis.Cardiacfunction is one of the most important indexes used to judge the degree of myocardial injury.The presentstudy attempted to determine whether in vivo administration of L-arginine at different stages of MI/R has adiverse influence on cardiac function of ischemic reperfused hearts and,if so,to investigate the mechanismsinvolved.Male adult rats were subjected to 30 min myocardial ischemia followed by 5 h reperfusion.Anintravenous L-arginine bolus was given either 10 min before and 50 min after reperfusion(early treatment)or3 h and 4 h after reperfusion(late treatment).Early treatment with L-arginine markedly increased the leftventricular systolic pressure(LVSP)and dP/dt_(max),and decreased myocardial nitrotyrosine content.In strictcontrast,late treatment with L-arginine resulted in a significant decrease in LVSP and dP/dt_(max)from 4 h to 5h after reperfusion,and increase in toxic peroxynitrite formation as measured by nitrotyrosine.These resultssuggest that the administration of L-arginine at different time points during the course of MI/R leads todiverse effects on cardiac dysfunction.Early supplementation decreased the nitrative stress and improvedleft ventricular function.However,late treatment with L-arginine increased the formation of peroxynitriteand aggravated cardiac functional injury.     

Intestinal iron absorption and mucosal transferrin in rats subjected to hypoxia

Three days hypoxia (0.5 atm) increased the haemoglobin and haematocrit values in rats paralleled by enhanced intestinal iron absorption. The destination of recently-absorbed iron was primarily the erythropoietic system, viz. bone marrow, spleen and red cells. Total plasma transferrin, was increased by 30%, but no significant changes in mucosal transferrin were found. No increase in labelling of mucosal transferrin by absorbed iron was observed. These results suggest that mucosal transferrin does not play a major role in the regulation of intestinal iron absorption in hypoxia.